Whether the longitudinal profile of MDA and MMP-9 in CKD nondialysis-dependent patients and PD patients, both with signs of CMS, provides additional information on the predictive power of these biomarkers for the progression of atherosclerosis remains a question for testing in future longitudinal studies with a larger number of patients. This evidence concerns the gene MMP9 and chronic kidney disease.